Valneva Austria GmbH
Commercial
Also recorded in the register as: VALNEVA AUSTRIA GMBH. These spellings have been reviewed and merged onto this page — see data/organisation-aliases.json in the repository.
- Sector
- Companies
- Agreements as applicant
- 1
- In term in September 2026
- 0
- Distinct datasets
- 1
- Files released
- 0
- Latest agreement end date
- 30 November 2021
Files released counts only files released externally by DARS. Access granted in NHS England's own systems, such as its Secure Data Environment, is not included.
Agreements
| Agreement | Datasets | Files | Latest term | Status | Commercial |
|---|---|---|---|---|---|
| A RANDOMIZED, OBSERVER-BLIND, CONTROLLED, SUPERIORITY STUDY TO COMPARE THE IMMUNOGENICITY AGAINST COVID-19, OF VLA2001 VACCINE TO AZD1222 VACCINE, IN ADULTS. DARS-NIC-418208-J1Y6J | 1 | 0 | 23 March 2021 to 30 November 2021 | Expired | Yes |
Datasets named in its agreements
Cite this page
NHS England (2026) Data Uses Register, September 2026 edition, agreements naming Valneva Austria GmbH. Read via NHS Data Access Explorer (unofficial), https://healthdatauses.uk/organisations/valneva-austria-gmbh/ (accessed [date]).
This address stays the same, but the page is rebuilt with each monthly edition, so the citation names the edition it shows. Every edition's data is kept in the facts store.